Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$565M |
| 2 |
Shopify
SHOP
|
+$376M |
| 3 |
Alibaba
BABA
|
+$289M |
| 4 |
NovoCure
NVCR
|
+$170M |
| 5 |
Spotify
SPOT
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
C.H. Robinson
CHRW
|
+$393M |
| 2 |
Under Armour
UAA
|
+$311M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Stellantis
STLA
|
+$203M |
| 5 |
Meta Platforms (Facebook)
META
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 33.91% |
| 2 | Communication Services | 17.09% |
| 3 | Healthcare | 16.31% |
| 4 | Financials | 10.01% |
| 5 | Technology | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Invesco Senior Income Trust
VVR
$456M
| $13.9M | 0.02% |
3,310,700
| – | – |
|
177
Infosys
INFY
$50.2B
| $13.5M | 0.01% |
1,235,872
+17,203
| +1% | +$182K |
|
178
Evolent Health
EVH
$411M
| $13.5M | 0.01% |
1,073,384
+42,631
| +4% | +$675K |
|
|
ONC
179
BeOne Medicines Ltd
ONC
$36.5B
| $12.6M | 0.01% |
95,574
+858
| +0.9% | +$116K |
|
180
Xylem
XYL
$28.2B
| $12.4M | 0.01% |
156,570
+16,234
| +12% | +$1.18M |
|
|
MRC
181
DELISTED
MRC Global
MRC
| $11.4M | 0.01% |
650,000
| – | – |
|
182
CEVA Inc
CEVA
$990M
| $11.3M | 0.01% |
417,766
+24,545
| +6% | +$666K |
|
|
LN
183
DELISTED
LINE Corporation
LN
| $10.8M | 0.01% |
307,597
-21,659
| -7% | -$780K |
|
184
BlackRock Floating Rate Income Trust
BGT
$323M
| $9.79M | 0.01% |
802,170
| – | – |
|
185
Ecolab
ECL
$79.3B
| $9.34M | 0.01% |
52,929
+5,401
| +11% | +$877K |
|
186
Adicet Bio
ACET
$75.4M
| $8.67M | 0.01% |
11,352
+2,570
| +29% | +$2.34M |
|
187
British American Tobacco
BTI
$127B
| $8.63M | 0.01% |
206,984
+69,144
| +50% | +$2.52M |
|
188
Sherwin-Williams
SHW
$88.3B
| $8.44M | 0.01% |
58,752
| – | – |
|
|
SINA
189
DELISTED
Sina Corp
SINA
| $7.79M | 0.01% |
131,550
| – | – |
|
|
CELG
190
DELISTED
Celgene Corp
CELG
| $7.4M | 0.01% |
78,398
-980,113
| -93% | -$85.7M |
|
191
HUTCHMED
HCM
$2.04B
| $6.75M | 0.01% |
220,896
+21,937
| +11% | +$547K |
|
|
UXIN
192
Uxin Ltd
UXIN
$222M
| $6.73M | 0.01% |
17,761
+5,277
| +42% | +$2.03M |
|
|
KLDO
193
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $6.38M | 0.01% |
+440,000
| New | +$6.06M |
|
|
PHD
194
DELISTED
Pioneer Floating Rate Fund
PHD
| $5.73M | 0.01% |
550,936
| – | – |
|
|
LXFT
195
DELISTED
Luxoft Holding, Inc.
LXFT
| $5.69M | 0.01% |
96,930
| – | – |
|
196
SLB Ltd
SLB
$77B
| $4.82M | 0.01% |
110,529
| – | – |
|
197
Lincoln Electric
LECO
$15.2B
| $4.29M | ﹤0.01% |
51,216
| – | – |
|
|
BCRH
198
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $4.24M | ﹤0.01% |
629,438
| – | – |
|
199
Rio Tinto
RIO
$163B
| $4.16M | ﹤0.01% |
70,626
| – | – |
|
|
BRW
200
Saba Capital Income & Opportunities Fund
BRW
$342M
| $3.65M | ﹤0.01% |
382,200
| – | – |
|
Similar funds
Baillie Gifford & Co's Q1 2019 Portfolio in Review
As of Q1 2019, Baillie Gifford & Co held 236 positions worth $91.4B, up 19% from $77B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Baillie Gifford & Co's Q1 2019 filing shows 10 new, 116 increased, 68 reduced and 9 closed positions. Its largest new stake was Vale: 10,553,700 shares worth $138M. The largest sale was C.H. Robinson, an estimated $393M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 34% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q1 2019 buy was Vale: 10,553,700 shares worth $138M.
- Baillie Gifford & Co added most to Microsoft in Q1 2019, an estimated $565M increase.
- Baillie Gifford & Co's biggest Q1 2019 reduction was C.H. Robinson, cutting an estimated $393M.
- Baillie Gifford & Co fully exited Under Armour in Q1 2019, selling an estimated $311M.
- Baillie Gifford & Co's ten largest holdings make up 45% of its $91.4B portfolio in Q1 2019.
- Baillie Gifford & Co opened 10 new positions and closed 9 in Q1 2019.
- Baillie Gifford & Co's portfolio value rose 19% quarter-over-quarter to $91.4B.
Based on Baillie Gifford & Co's 13F filing for Q1 2019, filed 1 May 2019.